Company intelligence / Profile preview
Newport Pharmaceuticals Limited
- Ownership
- Private
- Employees
- ~15
- Development stage
- Commercial
Overview
Newport Pharmaceuticals Limited, based in Dublin, Ireland, has operated for over 30 years. Its lead product, Inosine Acedoben Dimepranol (IAD), has been licensed internationally since the early 1970s to treat cell-mediated immune deficiencies linked to viral infections. The company continues to generate clinical data on IAD for niche applications and explores new formulations and manufacturing optimizations. It maintains a specialty pharma focus with strategic operations targeting Central Eastern Europe.
- Therapeutic areas
- Immunology
- Modalities
- Small molecules (notably Inosine Acedoben Dimepranol - IAD)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Newport Pharmaceuticals Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Newport Pharmaceuticals Limited.